Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | PCVX | NUVL | ||
| Company | Verona Pharma Plc ADR | Vaxcyte Inc | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.85 | 61.91 | 108.45 | ||
| High | 106.93 | 62.10 | 108.45 | ||
| Low | 106.81 | 60.00 | 105.64 | ||
| Latest | 106.91 | 60.55 | 107.13 | ||
| Change | +0.12 | -1.44 | -1.11 | ||
| % Change | +0.11% | -2.32% | -1.03% | ||
| Volume | 1,871,900 | 1,014,742 | 787,207 | ||
| 20-Day Average Volume | 1,504,320 | 1,233,407 | 617,175 | ||
| Previous Close | 106.79 | 61.99 | 108.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 59.18 | 102.89 | ||
| 20-Day Raw Stochastic | 98.26% | 73.89% | 88.64% | ||
| 20-Day Relative Strength | 70.52 | 55.06 | 57.57 | ||
| Weighted Alpha | +201.62 | +83.05 | +44.36 | ||
| Today's Opinion | 100% Buy | 100% Buy | 72% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | -3.52% since 04/14/26 | +2.01% since 04/14/26 | ||
| Low | 106.61 on 09/30/25 | 60.00 on 04/21/26 | 101.79 on 04/16/26 | ||
| High | 106.93 on 10/06/25 | 63.31 on 04/17/26 | 108.82 on 04/17/26 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | +10.65% since 03/20/26 | +13.04% since 03/20/26 | ||
| Low | 105.78 on 09/19/25 | 52.74 on 03/30/26 | 93.91 on 03/24/26 | ||
| High | 106.93 on 10/06/25 | 63.31 on 04/17/26 | 108.82 on 04/17/26 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | +20.57% since 01/21/26 | -1.75% since 01/21/26 | ||
| Low | 86.63 on 07/08/25 | 49.75 on 01/22/26 | 93.91 on 03/24/26 | ||
| High | 106.93 on 10/06/25 | 65.00 on 02/25/26 | 113.01 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +42.98% since 10/21/25 | +10.24% since 10/21/25 | ||
| Low | 47.20 on 04/07/25 | 39.87 on 11/05/25 | 89.02 on 11/05/25 | ||
| High | 106.93 on 10/06/25 | 65.00 on 02/25/26 | 113.01 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 8,921,600 | 8,509,502 | ||
| Shares Outstanding, K | 81,830 | 143,920 | 78,617 | ||
| Annual Sales | 42,280,000 | 0 | 0 | ||
| Annual Net Income | -173,420,000 | -766,630,000 | -425,380,000 | ||
| Last Quarter Sales | 103,140,000 | 0 | 0 | ||
| Last Quarter Net Income | 11,920,000 | -246,510,000 | -118,710,000 | ||
| 60-Month Beta | 0.05 | 1.38 | 1.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | -1.80 on 02/24/26 | -1.29 on 02/26/26 | ||
| Latest Earnings Date | 11/03/25 | 05/06/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||